Paulus Stoffels
2012
In 2012, Paulus Stoffels earned a total compensation of $7.3M as Chief Scientific Officer; Worldwide Chair, Pharmaceuticals at Johnson & Johnson.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,095,000 |
|---|---|
| Non-Equity Incentive Plan | $2,305,251 |
| Option Awards | $1,023,570 |
| Salary | $825,385 |
| Stock Awards | $1,926,252 |
| Other | $161,466 |
| Total | $7,336,924 |
Stoffels received $2.3M in non-equity incentive plan, accounting for 31% of the total pay in 2012.
Stoffels also received $1.1M of change in pension value and nonqualified deferred compensation earnings, $1M in option awards, $825.4K in salary, $1.9M in stock awards and $161.5K in other compensation.
Rankings
In 2012, Paulus Stoffels' compensation ranked 705th out of 11,487 executives tracked by ExecPay. In other words, Stoffels earned more than 93.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 705 out of 11,487 | 94th |
Division Manufacturing | 256 out of 4,253 | 94th |
Major group Chemicals And Allied Products | 58 out of 1,198 | 95th |
Industry group Drugs | 30 out of 920 | 97th |
Industry Pharmaceutical Preparations | 27 out of 700 | 96th |
Source: SEC filing on March 12, 2014.
Stoffels' colleagues
We found five more compensation records of executives who worked with Paulus Stoffels at Johnson & Johnson in 2012.